Theralase Technologies Inc. (CVE:TLT – Get Free Report)’s share price shot up 3.8% during trading on Tuesday . The stock traded as high as C$0.28 and last traded at C$0.27. 57,198 shares changed hands during mid-day trading, a decline of 78% from the average session volume of 255,032 shares. The stock had previously closed at C$0.26.
Theralase Technologies Price Performance
The firm has a fifty day moving average price of C$0.20 and a two-hundred day moving average price of C$0.20. The company has a quick ratio of 3.40, a current ratio of 1.91 and a debt-to-equity ratio of 14.85. The stock has a market capitalization of C$71.53 million, a P/E ratio of -15.00 and a beta of -0.13.
About Theralase Technologies
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
Featured Stories
- Five stocks we like better than Theralase Technologies
- The day the gold market broke
- Buy this Gold Stock Before May 2026
- Forget AI, This Will Be the Next Big Tech Breakthrough
- ALERT: Drop these 5 stocks before January 2026!
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
